Hasil Pencarian (1)
biotech | CAS: 347396-82-1
Ranibizumab is a recombinant humanized IgG1 kappa isotype monoclonal antibody fragment directed against human vascular endothelial growth factor A (VEGF-A), which is a glycoprotein implicated in the pathophysiology of age-related macular degeneration.[A2301, …
Kategori:
Amino Acids, Peptides, and ProteinsAngiogenesis InhibitorsAngiogenesis Modulating Agents
+19
Target Protein:
Vascular endothelial growth factor A, long form
Waktu ParuhThe estimated avera…
Vol. DistribusiThe apparent volume…
KlirensIn patients with re…
Genetik
-